<DOC>
	<DOCNO>NCT01089283</DOCNO>
	<brief_summary>Parkinson disease one common neurodegenerative illness . The disease characterize decrease dopamine level decrease number dopaminergic neuron dopamine receptor . There gene mutation increase risk disease . Two mutation LRRK2 gene GBA gene . It yet unknown difference metabolic brain function Parkinson patient carry one two mutation Parkinson patient know mutation . Participants : diagnose Parkinson patient carry gene mutation either LRRK2 GBA gene , Parkinson patient know mutation healthy volunteer control group . The participant go examination DAT SCAN PET CT SCAN Tel Aviv Sourasky Medical Center Nuclear Medicine Institute . The examination result give participant doctor neurology department .</brief_summary>
	<brief_title>Ioflupane I123 ( DaTSCAN ) Positron Emission Tomography-computed Tomography Fludeoxyglucose ( PET-CT FDG ) Assess Brain Function Parkinson Patients With Different Genetic Characteristics</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>diagnose Parkinson patient know genetic characteristic patient unable understand sign inform consent minor patient medical condition allow stay still examination</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>parkinson</keyword>
	<keyword>fdg pet-ct</keyword>
	<keyword>i123 dat scan</keyword>
	<keyword>LRRK2</keyword>
	<keyword>GBA</keyword>
	<keyword>parkinson patient know genetic characteristic</keyword>
</DOC>